Milind Deshpande - Insider Trading & Ownership

Entity: Individual
Location: Achillion Pharmaceuticals, 300 George Street, New Haven, CT
Summary: The estimated net worth of Milind Deshpande is at least $104K dollars as of May 30, 2024. Milind Deshpande is the Director of Spero Therapeutics, Inc. and owns shares of Spero Therapeutics, Inc. (SPRO) stock worth about $104K.
All Insider Reports: All Insider Reports

Ownership of Milind Deshpande

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
SPRO	Spero Therapeutics, Inc.	Director	$104K			May 29, 2024

Showing 1 to 1 of 1 entries

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership
Loading...

Showing 0 to 0 of 0 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.